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Summary  
Urinary tract infection (UTI) syndromes are a common reason for empirical antibiotic 
prescribing in the Emergency Department (ED).  We investigated the role of microbiological 
culture and urinalysis in the diagnosis of pyelonephritis by extracting data on 105 patients with 
a clinical diagnosis of pyelonephritis at a London teaching hospital.  
96/102 patients were treated empirically with intravenous antibiotics but only 55/100 patients 
who were sampled had microbiological evidence of infection in urine and/or blood. Almost half 
(10/21) of patients with a negative urine dipstick test had a positive urine culture.  Diagnostic 
uncertainty in this context undoubtedly drives inappropriate antibiotic use. 
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Introduction 
 
Urinary tract infections are a common reason for hospital admission affecting an estimated 
150 million people per year worldwide.[1] More than half of women will experience at least one 
UTI in their lifetime with an estimated societal cost of $3.5 billion per year in the United States 
alone.[2–4]  
UTIs are differentiated into lower (cystitis) and upper UTIs (pyelonephritis) based on the 
patients clinical presentation.  Cystitis is usually managed in the community but patients with 
pyelonephritis may require hospital admission for treatment with intravenous antibiotics.[5]  
Distinguishing UTI from other diseases with a similar clinical presentation can be difficult, 
particularly in settings such as the Emergency Department (ED) where diagnostic information 
may be limited and there is a need to make rapid treatment decisions.[6] Physicians often rely 
upon imperfect laboratory or bedside tests such as urinalysis to support clinical decisions 
around the need for empirical antibiotics, despite the fact that these tests lack the sensitivity 
and specificity to distinguish bacterial UTI in an individual patient.  Microbial culture can identify 
the cause of infection and may be important to guide the choice of antibiotic therapy, 
particularly in the context of antimicrobial resistance.  However the results of culture-based 
tests take at least 48 hours, by which time many patients have either recovered or been 
discharged from hospital. 
We investigated the contribution that urinalysis and microbial culture make to the diagnosis of 
pyelonephritis to assess for evidence of a mismatch between clinical and microbiological 
diagnosis.  
 
Materials and methods 
We undertook a cohort study in adult patients with a clinical diagnosis of pyelonephritis.  
Patients were eligible for the study if that had been admitted to University College London 
Hospital (UCLH) via the ED between 29/12/2014 and 5/2/2016. 
UCLH is a central London teaching hospital which provides care to approximately 1 million 
outpatients and 170,000 admitted patients per year. Medical staff extracted demographic, 
clinical and microbiological data from the hospital records for cases of pyelonephritis, defined 
by: evidence of infection (at least one of: core temperature >37.5℃, rigors, elevated peripheral 
blood white cell count or C reactive protein); evidence of a urinary source (at least one of 
dysuria or increased urinary frequency, bacteriuria, urinary leukocytes or urinary nitrites); and 
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renal involvement (renal angle tenderness or radiological evidence of renal or perinephric 
inflammatory changes). To confirm the diagnosis of pyelonephritis, the responsible medical 
Consultant for each case reviewed all the available clinical data.  Admission details, 
examination, urinalysis, microbiological results and antibiotic choice were extracted from 
electronic and paper hospital records. All data were recorded directly into an Excel 
spreadsheet and analysed using Stata 14. We estimated the proportion of patients with a 
microbiological diagnosis of UTI and/or abnormal urinalysis and assessed patterns of 
antibiotic prescribing and antimicrobial resistance.  A positive microbiological culture was 
defined as identification of a pathogen in either blood and/or urine, taking a colony count of > 
105 cfu/mL as the laboratory cut-off for bacteriuria. Micrococcus, coagulase negative 
staphylococci and candida were classified as contaminants.  
To investigate the role of urinalysis in the diagnosis of pyelonephritis, we evaluated the 
performance of this test compared to urine culture by calculating sensitivity, specificity and 
positive and negative predictive values. 
The data presented in this study were collected as part of routine care and audit at the Trust.  
Ethical approval for this study was therefore not required. 
 
Results 
Data were available for 105 patients with a clinical diagnosis of pyelonephritis.  The median 
age was 29.3 years (IQR 22.7-51.1) and 84.9% (84/99) of patients were female.  The majority 
of patients (80/105) were clinically well at admission with a low national early warning score 
(NEWS),[7] and the median duration of hospital admission was 3 days (IQR 2-4 days).    
Information on antibiotic treatment was available for patients 102/105 patients, 99 of whom 
were treated empirically with intravenous antibiotics on admission to hospital. 87/105 (82.9%) 
patients were treated empirically with one intravenous antibiotic, 11 (10.5%) were prescribed 
two antibiotics and 1 (1.0%) patient was treated empirically with 3 antibiotics.  Three patients 
were treated with oral ciprofloxacin and for the remaining three patients antibiotic treatment 
was either not given or not recorded. Cefuroxime was most commonly prescribed as the first-
line antibiotic, Table I. 99/105 (94.2%) patients were treated with oral step-down antibiotics, 
with ciprofloxacin as the commonest choice (76/105) patients. 85/88 (96.6%) patients for 
whom a urine culture was submitted were treated with intravenous antibiotics. 
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Urine dipstick tests were performed in 104 patients and were negative in 24 (23.1%).  A 
pathogen was identified from 49/88 (55.7%) urine culture samples and from 17/91 (18.7%) 
blood cultures.  11 patients had both a positive urine and blood culture. Blood and/or urine 
specimens were submitted for culture in 100/105 patients and overall 55/105 (52.4%) patients 
had microbiological evidence of infection. None of the individual components of the urine 
dipstick test reliably predicted bacteriuria.  79% of patients with bacteriuria had a positive 
urinalysis, defined as at least one abnormal component of the test.  By contrast urinalysis was 
negative in only 11/37 patients who did not have clinically relevant bacteriuria, Error! 
Reference source not found.. 
E.coli was identified from urine and/or blood in 49/105 patients (46.7%) and three patients 
(2.9%) had E.coli with extended spectrum beta-lactamases (ESBLs).  A single case was 
identified for each of Klebsiella (blood and urine), Proteus (urine) and Pseudomonas (urine).  
 
Discussion 
The majority of patients in this study were treated empirically with intravenous antibiotics, yet 
almost half of them had no microbiological evidence of infection.  Microbiological investigations 
were undertaken for the majority of these patients, highlighting the discrepancy between 
clinical and microbiological diagnosis in patients with suspected pyelonephritis.  
Patients with a clinical diagnosis of pyelonephritis would be expected to have a positive urine 
culture, although up to 20% of women with pyelonephritis have urine cultures with <105 cfu/mL, 
leading to false negative culture results.[11] Previous studies have also suggested that 15-
20% of women who are admitted to hospital with pyelonephritis have bacteraemia, highlighting 
the need for blood culture sampling in these patients.[11,12]  Possible explanations for the low 
rate of microbiological diagnosis in our cohort could relate to the diagnostic threshold that was 
used to identify suspected cases, tending to over-diagnose pyelonephritis.  However the 
clinical diagnosis for each case was verified by the responsible medical Consultant which 
makes this explanation less plausible.  It is possible that specimens were collected after the 
patient had already started antibiotic treatment, which could potentially reduce the likelihood 
of obtaining a culture result.[10]  Meanwhile factors affecting the processing or transportation 
of urine specimens would tend to overestimate rather than underestimate the prevalence of 
bacteriuria.[11] Perhaps the most likely explanation for the low rate of microbiological 
diagnosis relates to the cut-off values which are used to define bacteriuria, which in common 
with most laboratories are defined as the presence of >105 cfu per mL of urine.[12]  These cut-
off values were defined for women with acute pyelonephritis and may underestimate the 
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prevalence of bacteriuria in other patient populations.[12]  For this reason some guidelines 
recommend the use of lower cut-off values in the diagnosis of UTI. [5,13]  
Urinalysis is generally regarded as a test with low sensitivity and high specificity making it well 
suited to rule out significant bacteriuria.[8]  In our study the positive predictive value of the 
urinalysis tests for leukocyte esterase and nitrites were comparable to those reported in the 
literature.[8]  However, we found the negative predictive value of these tests to be around 
50%, significantly lower than the reported 80-90%.[8] Urinalysis has been shown to be of value 
to rule out UTI in settings with a low rate of culture-positive UTI,[9] but the role of urinalysis in 
settings where patients have a high probability of infection has previously been 
questioned.[10] Alternatively the low NPV could reflect difficulties with how urinalysis results 
are read or recorded in the context of a busy ED.  
The major limitation of our study is that it was conducted at a single site.  We did not collect 
information on symptoms, but all the study participants had a clinical diagnosis of 
pyelonephritis so we anticipate that the prevalence of asymptomatic bacteriuria would be low 
in this cohort.  In addition, information was not extracted on whether the patient was 
catheterised when the urine specimen was collected, although usually this information would 
be communicated to the microbiology laboratory and used to inform selection of appropriate 
cut off values for bacteriuria.[(12)] 
Taken together, the extent to which our findings represent false negative microbiological tests 
or over-diagnosis of UTI is difficult to disentangle.  Either way, our study highlights a greater 
discrepancy between clinical and microbiological diagnosis of pyelonephritis than has been 
reported in previous studies.(18)] This diagnostic uncertainty undoubtedly contributes to 
inappropriate antibiotic use and antimicrobial resistance. There is a clear need to develop and 
implement novel diagnostic strategies in the ED to reliably differentiate patients who require 
antibiotic treatment for UTI syndromes. 
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Table I.  Empirical antibiotic treatment and relationship to microbial culture 
Intravenous drug 
treatment1 
Number of 
patients 
Number of patients with at least one 
positive microbial culture (%)2 
Cefuroxime 87  44 (52.4) 
Co-amoxiclav 5 5 (100) 
Gentamicin 6  5 (83.3) 
Flucloxacillin 1  1 (100) 
Ciprofloxacin 2  2 (100) 
Daptomycin 1  1 (100) 
Teicoplanin 1  1 (100) 
Piperacillin-
Tazobactam 
2 2 (100) 
Carbapenem 7  5 (71.4) 
 
  
                                                          
1 A single antibiotic was prescribed empirically for 87 patients, 11 patients were prescribed two antibiotics and 
one patient was treated empirically with three antibiotics.  For six patients antibiotic treatment was either not 
prescribed or not recorded. 
2 Excluding contaminants 
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Table II. Test performance of urinalysis to predict bacteriuria1 
Component of 
urinary Test  
Number of patients 
with positive test (%) 
Sensitivity2 
(%) 
Specificity3 
(%) 
Positive predictive 
value 3 - PPV (%) 
Negative predictive 
value4 - NPV (%) 
Blood 63 (60.6)  30/48 (62.5) 18/37 (48.7) 30/49 (61.2) 18/36 (50.0) 
Leukocytes 67 (64.4) 33/48 (68.8) 16/37 (43.2) 33/54 (61.1) 16/31 (51.6) 
Protein 46 (44.2) 23/48 (47.9) 22/37 (59.5) 23/38 (60.5) 22/47 (46.8) 
Nitrites 35 (33.7) 22/48 (45.8) 26/37 (70.3) 22/33 (66.7) 26/52 (50.0) 
Glucose 2 (1.9) 2/48 (4.2) 37/37 (100) 2/2 (100.0) 37/83 (44.6) 
Ketones 22 (21.2) 12/48 (25.0) 31/37 (83.8) 12/18 (66.7) 31/67 (46.3) 
Negative test4 24 (23.1) 11/37 (29.7) 38/48 (79.2) 11/21 (52.4) 38/64 (59.4) 
Total 104 (100)     
                                                          
1 Analysis of test performance restricted to 85 patients who had both urinalysis and urine culture performed (contaminants excluded) 
2 Sensitivity is the proportion of true positives that are correctly identified by the test; specificity is the proportion to true negatives that are correctly identified by the test 
3 PPV: Proportion of urinalysis test positives confirmed as positive by urine culture; NPV Proportion of urinalysis test negatives confirmed negative by urine culture 
4 To exclude bacteriuria i.e. a negative urinalysis was reported in 11/37 patients without bacteriuria; urinalysis was positive in 38/48 patients with bacteriuria. 
12 
 
 
